Capricor Therapeutics
CAPR
CAPR
115 hedge funds and large institutions have $104M invested in Capricor Therapeutics in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 26 increasing their positions, 36 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
24% less capital invested
Capital invested by funds: $137M → $104M (-$32.4M)
28% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 36
Holders
115
Holding in Top 10
1
Calls
$33.9M
Puts
$25.9M
Top Buyers
| 1 | +$3.55M | |
| 2 | +$3.46M | |
| 3 | +$1.95M | |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$1.69M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.59M |
Top Sellers
| 1 | -$4.9M | |
| 2 | -$3.13M | |
| 3 | -$2.31M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.7M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$915K |